MSH|^~\&|LAB|ARH|||202002261121||ORU^R01|4176206|D|2.3|||AL|NE
PID|1||AB00007803|PA2506|LABTEST^ALLOSAURUS^||19851121|F||||||||||AB000896/18|9875619677
OBR|1|39629^LAB|00029880^2002:C00010R^LAB^200220:C10^39629|500.2060^KSTIM120^Potassium, 120 min post^^XBC4573-7^XBC4573-7||202002200916|202002201115|||||||202002201120||||||||||LAB|F||||
OBX|1|ST|500.2060^KSTIM120^Potassium, 120 min post^^XBC4573-7^XBC4573-7|1|5.2^^Y|mmol/L||N||A^S|F|||202002200922
OBR|2|39629^LAB|00029880^2002:C00010R^LAB^200220:C10^39629|520.1785^GLUSTIM120^Glucose, 120 min post^^25668-5^25668-5||202002200916|202002201115|||||||202002201120||||||||||LAB|F||||
OBX|1|ST|520.1785^GLUSTIM120^Glucose, 120 min post^^25668-5^25668-5|1|3.8^^Y|mmol/L||N||A^S|F|||202002200922
OBR|3|39629^LAB|00029880^2002:C00010R^LAB^200220:C10^39629|521.4600^GH120^Growth Hormone, 120 Min Post^^X50103^||202002200916|202002201115|||||||202002201120||||||||||LAB|F||||
OBX|1|ST|521.4600^GH120^Growth Hormone, 120 Min Post^^X50103^|1|^^Y|||N||A^S|F|||202002261121
NTE|1||For results refer to PLIS, UCI, Excelleris or CareConnect.
NTE|2||If you are unable to access results, please contact the
NTE|3||testing site.

MSH|^~\&|MIC|RMH|||202002261122||ORU^R01|4176217|D|2.3|||AL|NE
PID|1||RM00003593|RM3179|PHATEST^RMH1^|||F||||||||||RM000118/19|
OBR|1|39854^MIC|00030048^20:MT0000089R^MIC^20:MT89^39854|700.1950^CDT^C. difficile Assay^^^XXX-2144||202002261120|202002251120|||||||202002261120|Stool^^^|||||||||MB|F||||
OBX|1|CE|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8^O:NATCDIFF|1.1|NATCDIFF^C. difficile toxin B detected||||||F|||202002261122
OBX|2|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1.1|||||||F|||202002261122
NTE|1||Patients positive for the C. difficile toxin B gene should
NTE|2||not have a test of cure as the test may remain positive for
NTE|3||months after symptom resolution.
NTE|4||Approximately 25% of adequately treated patients will have a
NTE|5||relapse of C. difficile disease. Repeat C. difficile testing
NTE|6||is not helpful.
NTE|7||
NTE|8||A copy of these results has been sent to Infection
NTE|9||Prevention and Control.
NTE|10||
NTE|11||For mild or first recurrent Clostridium difficile associated
NTE|12||diarrhea in adults, treatment with oral vancomycin is now
NTE|13||considered more effective than metronidazole.  Consult
NTE|14||Infectious Disease Society of America (IDSA) 2017
NTE|15||C.difficile guideline or UpToDate.